- Home
- RNXT vs APT Comparison
RNXT vs APT Comparison
Compare RNXT & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- APT
- Stock Information
- Founded
- RNXT 2012
- APT 1983
- Country
- RNXT United States
- APT Canada
- Employees
- RNXT N/A
- APT N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- RNXT Health Care
- APT
- Exchange
- RNXT Nasdaq
- APT Nasdaq
- Market Cap
- RNXT 44.6M
- APT 50.5M
- IPO Year
- RNXT 2021
- APT 1995
- Fundamental
- Price
- RNXT $1.30
- APT $4.84
- Analyst Decision
- RNXT Strong Buy
- APT
- Analyst Count
- RNXT 2
- APT 0
- Target Price
- RNXT $7.25
- APT N/A
- AVG Volume (30 Days)
- RNXT 135.9K
- APT 14.1K
- Earning Date
- RNXT 08-12-2025
- APT 08-06-2025
- Dividend Yield
- RNXT N/A
- APT N/A
- EPS Growth
- RNXT N/A
- APT 2.28
- EPS
- RNXT N/A
- APT 0.36
- Revenue
- RNXT $240,000.00
- APT $58,180,000.00
- Revenue This Year
- RNXT $3,104.65
- APT N/A
- Revenue Next Year
- RNXT $301.89
- APT N/A
- P/E Ratio
- RNXT N/A
- APT $13.45
- Revenue Growth
- RNXT N/A
- APT N/A
- 52 Week Low
- RNXT $0.75
- APT $4.06
- 52 Week High
- RNXT $1.69
- APT $6.44
- Technical
- Relative Strength Index (RSI)
- RNXT 53.41
- APT 57.40
- Support Level
- RNXT $1.29
- APT $4.69
- Resistance Level
- RNXT $1.38
- APT $4.97
- Average True Range (ATR)
- RNXT 0.07
- APT 0.16
- MACD
- RNXT -0.01
- APT 0.01
- Stochastic Oscillator
- RNXT 48.39
- APT 59.61
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.